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506Objectives: Infective endocarditis is rare in children but potentially carries high mortality and morbidity. Few
data exist regarding surgical therapy and the associated outcomes in children with infective endocarditis. The
aim of the present study was to describe the characteristics and outcomes of children undergoing surgery for
infective endocarditis.
Methods: A retrospective review of all patients aged 21 years or younger diagnosed with definitive infective
endocarditis at a single center from 1996 to 2010 was performed.
Results: Of 76 identified patients with infective endocarditis (median age, 8.3 years; 73.9% boys), 46 patients
(61%) required surgical intervention. Staphylococcus aureus was most commonly isolated (18 patients, 24%)
followed by Streptococcus (17 patients, 22%). Common surgical indications included severe valvular insuffi-
ciency in 13 patients, septic embolization in 12, concomitant severe valvular insufficiency and ventricular dys-
function in 9, persistent vegetations in 9, and persistent bacteremia in 3. Although early surgery was performed
within 7 days of diagnosis in 35 patients (76%), 25 (54%) underwent surgery within 3 days or less. The factors
associated with surgery included the presence of ventricular dysfunction, left-sided vegetation, severe valvular
insufficiency, septic embolization, and S aureus. Surgery within 3 days or less was associated with the presence
of ventricular dysfunction and S aureus. Native valve repair was performed in 50% of patients with native-valve
disease. Postoperatively, no septic embolization events occurred and recurrence was low (2%). The 1-, 5-, and
10-year survival was 98%  2%, 90%  8%, and 81%  11%, respectively.
Conclusions: Children with infective endocarditis can undergo successful early surgical therapy with a low risk
of septic embolization, recurrence, and operative mortality. (J Thorac Cardiovasc Surg 2013;146:506-11)Infective endocarditis (IE), although relatively uncommon
in children,1,2 is a serious infection associated with
significant morbidity and mortality.1-3 Effective treatment
of IE typically involves prolonged medical therapy with
intravenous antibiotics, which can be combined with
surgical therapy in some patients.4-8 Often in complicated
IE, the decision between surgical versus medical therapy
can be complex.
The presence of congenital heart disease represents a sig-
nificant difference between adult and pediatric populations
and affects the epidemiology, treatment, and outcomes of
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by the American Academy of Pediatrics, the recommenda-
tions were determined from adult data, and generalization
to the pediatric population might not be appropriate. Data
describing the surgical experience in children with IE are
sparse, and, as such, no pediatric-specific surgical indica-
tions have been published to date. It is notable that some
centers, particularly those in developing countries where
IE is more common, have adopted a strategy of aggressive,
early intervention (Drs Parvathi and Krishna Iyer, personal
communication, 2010).
Early surgical intervention during the acute phase of
infection has been associated with good outcomes in
adults.13-16 It is also very likely that optimal surgical
timing is likely crucial for improved outcomes in children.
However, to our knowledge, no data have examined the
effect of surgical timing on the outcomes in children.
To better understand the surgical indications, timing, and
outcomes of children with IE, we aimed to describe the
15-year surgical experience at a large, tertiary-care chil-
dren’s hospital.
METHODS
Patient Selection and Variables
We conducted a retrospective review of the pediatric cardiology and car-
diovascular surgery databases to identify patients diagnosed with IE atery c September 2013
Abbreviations and Acronyms
IE ¼ infective endocarditis
IQR ¼ interquartile range
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lor College of Medicine institutional review board approved the study.
All available medical records, laboratory results, imaging reports, and
surgical reports were reviewed. All patients 21 years old or younger who
were diagnosed with definitive IE, as outlined by the modified Duke crite-
ria,17 were included. In cases of recurrent IE, only the index case was in-
cluded in the present analysis. A history of congenital heart disease,
previous cardiac surgery, or the presence of prosthetic graft material was
not considered a criterion for exclusion. To improve subject homogeneity,
patients with probable endocarditis, as outlined by the modified Duke cri-
teria,17 were not included in the present study.
Definitions
The patients were categorized for analysis into either the medical or sur-
gical group according to the need for surgery as a part of their IE treatment
regimen. The surgical group was defined by the need for surgery for acute
IE within 6 weeks of starting appropriate intravenous antimicrobial
therapy.
Patients with congenital heart defects were grouped into 3 categories:
lesions with left to right shunting, lesions affecting the right ventricular out-
flow tract or requiring the creation of a right ventricle to pulmonary artery
conduit for repair, and lesions affecting the left ventricular outflow tract,
including bicuspid aortic valve.
Estimation of valvular insufficiency and cardiac function were taken di-
rectly from the echocardiographic data. The degree of valvular insuffi-
ciency was qualitatively determined by the reporting cardiologist.
Ventricular dysfunction was quantitatively defined as an ejection fraction
less than 55%18 or a shortening fraction less than 2 Z-scores for age and
size when the ejection fraction was not available.
Statistical Analysis
The data were not normally distributed. Descriptive statistics are re-
ported using the median and interquartile range (IQR) for scale variables
and proportions for categorical variables. Univariate analysis of categorical
variables was performed using the Pearson chi-square test or Fisher’s exact
test, as appropriate. Continuous variables were analyzed using the Mann-
Whitney U test. The multivariate factors associated with surgical timing
were determined by binary logistic regression analysis and are expressed
as odds ratios with 95% confidence intervals. All survival analyses were
performed using Cox regression analysis and are expressed as hazard ratios
and 95% confidence intervals. Kaplan-Meier survival analysis was used to
determine the 1-, 5-, and 10-year survival. The 2-tailed test of significance
was used in all statistical analyses.RESULTS
Patient Population
A total of 76 patients at a median age of 8.3 years (IQR,
2.1-14.4 years) whomet the inclusion criteria were included
in the present study. Of these 76 patients, 46 (60.5%) under-
went surgery as a part of their treatment regimen for acute
IE. The patient demographics are listed in Table 1. Al-
though no age or racial differences were found between
the 2 groups, those in the surgical group were more likely
to be male (P ¼ .016).The Journal of Thoracic and CaInfection Site
The infection site was identified in 23 nonsurgical
(76.7%) and 46 surgical (100%) patients. Native valve in-
volvement (43% vs 83%, P ¼ .020) and left-sided lesions
(27% vs 54%,P¼ .001) were more common in the surgical
group. The presence of congenital heart disease was not sig-
nificantly different between the 2 groups (P ¼ .172). The
specific infection sites are listed in Table 2.Causative Organisms
Positive culture data were obtained from 46 patients
(60.5%): 17 nonsurgical (56.7%) and 29 surgical
(63.0%) patients. Staphylococcus aureus and Streptococ-
cus infections were the most common isolated organisms,
occurring in 18 (23.7%) and 17 (22.4%) patients, respec-
tively. Of those with S aureus IE, methicillin-sensitive
S aureus was present in 13 patients and methicillin-
resistant S aureus was present in 5. In the subgroup
analysis, S aureus was the most common organism in the
surgical group (3% vs 37%, P  .001) and Streptococcus
occurred more frequently in the nonsurgical group
(33% vs 15%, P ¼ .019). No significant differences were
seen in the rates of coagulase-negative Staphylococcus in-
fection (13% vs 9%, P ¼ .270). Other organisms included
Escherichia coli in 1 surgical patient (2.2%), Serratia mar-
cescens in 1 nonsurgical patient (3.3%), and Entercoccus
faecalis in 1 nonsurgical patient (3.3%).Surgical Data
The most common indication for surgery was acute, se-
vere valvular insufficiency (22 patients, 47.9%). Of those,
9 patients (40.9%) also had evidence of concomitant ven-
tricular dysfunction. Septic embolization was present in
20 patients (43.5%) at surgery and was the primary surgical
indication in 12 patients (26.1%). Of those 12 patients, ce-
rebrovascular embolization occurred in 10, pulmonary em-
bolization in 1, and renal embolization in 1. Persistent
intracardiac vegetation, despite appropriate medical man-
agement, was present in 12 patients (26.1%). In these pa-
tients, the vegetations involved the tricuspid valve with
less than severe insufficiency in 5, the right ventricle with
less than severe tricuspid insufficiency in 4, the right atrium
with persistent positive blood culture findings in 2, and the
right atrium with evidence of inferior vena cava obstruction
in 1. Vegetations were documented in 39 patients (51.3%),
with 25 (64.1%) having a vegetation of 10 mm or greater
and 14 (35.9%) having a vegetation less than 10 mm. The
differences in disease characteristics between the 2 groups
are listed in Table 3.Timing of Surgery
The median interval to surgery was 3.0 days (IQR,
1.0-7.5 days) from the diagnosis of IE. Although mostrdiovascular Surgery c Volume 146, Number 3 507
TABLE 1. Patient demographics
Demographic
Nonsurgical
(n ¼ 30)
Surgical
(n ¼ 46) P value
Age (y) NS
Median 7.0 8.7
IQR 0.4-16.1 4.6-13.4
Male gender (n) 14 (46.7) 34 (73.9) .016
Race (n) NS
Asian 1 (3.3) 1 (2.2)
Black 3 (10.0) 7 (15.2)
Hispanic 9 (30.0) 20 (43.5)
White 14 (46.7) 18 (39.1)
Other 3 (10.0) 0 (0)
Congenital heart disease (n) 21 (70.0) 25 (54.3) NS
Shunt lesion 8 (38.1) 13 (52.0)
RVOT lesion 6 (28.6) 3 (12.0)
LVOT lesion 5 (23.8) 8 (32.0)
AVV lesion 2 (9.5) 1 (4.0)
Previous cardiac surgery (n) 11 (36.7) 8 (17.4) NS
Data in parentheses are percentages. IQR, Interquartile range; NS, not significant;
RVOT, right ventricular outflow tract lesion; LVOT, left ventricular outflow tract
lesion; AVV, atrioventricular valve.
TABLE 3. Disease characteristics
Characteristic
Nonsurgical
(n ¼ 30)
Surgical
(n ¼ 46) P value
Left-sided vegetation 8 (26.7) 25 (54.3) .001
Any valvular involvement 16 (53.3) 41 (89.6) NS
Valvular insufficiency
None or trivial 2 (6.7) 0 (0) .021
Mild 5 (16.7) 12 (26.1) NS
Moderate 7 (23.3) 12 (26.1) NS
Severe 2 (6.7) 17 (37.0) .037
Presence of ventricular dysfunction 0 (0) 9 (19.6) .010
Staphylococcus aureus 1 (3.3) 17 (37.0) <.001
Septic embolization 1 (3.3) 20 (43.5) <.001
Vegetation size  10 mm 2 (6.7) 23 (50.0) <.001
Data presented as n (%). NS, Not significant.
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diagnosis, a significant number (25, 54%) underwent sur-
gery within 3 days. The factors associated with surgery
within 3 days from diagnosis are listed in Table 4. On mul-
tivariate analysis, infection due to S aureuswas a significant
factor (odds ratio, 4.8; 95% confidence interval, 1.3-17.8)
for surgery within 3 days from diagnosis.Follow-up and Outcomes
The median patient follow-up period for the entire cohort
was 4.5 years (IQR, 1.3-7.1 years). No significant difference
was seen in the median follow-up between the nonsurgicalTABLE 2. Infection sites
Site
Nonsurgical
(n ¼ 30)
Surgical
(n ¼ 46) P value
Native valve 13 (43.3) 38 (82.6) .020
Tricuspid 7 (23.3) 14 (30.4) NS
Mitral 4 (13.3) 11 (23.9) NS
Aortic 1 (3.3) 7 (15.2) NS
Mitral plus aortic 0 (0) 4 (8.7) NS
Mitral plus tricuspid 1 (3.3) 2 (4.3) NS
Right atrium 3 (10.0) 3 (6.5) NS
RVOT 0 (0) 1 (2.2) NS
Left atrium 1 (3.3) 0 (0) NS
Left ventricle 2 (6.7) 0 (0) .029
Ascending aorta 0 (0) 1 (2.2) NS
RV-PA conduit valve 3 (10.0) 3 (6.5) NS
Prosthetic graft 1 (3.3) 0 (0) NS
Unknown 7 (23.3) 0 (0) NS
Data presented as n (%). NS, Not significant; RVOT, right ventricular outflow tract;
RV-PA, right ventricle to pulmonary artery.
508 The Journal of Thoracic and Cardiovascular Surggroup (median, 5.2 years; IQR, 2.8-7.9 years) and surgical
group (median, 3.8 years; IQR, 1.1-6.5 years; P ¼ .095).
The all-cause mortality of the entire cohort during the
follow-up period was 7.9% (6 patients). Although overall
mortality was lower in the surgical group (6.5% vs
10.0%), this difference did not reach statistical significance
(P ¼ .583). The 1-, 5-, and 10-year survival of the nonsur-
gical group was 96% 4%, 89% 7%, and 81% 10%,
respectively. Comparatively, survival among the surgical
group was 98%  2%, 90%  8%, and 81%  11%
at 1, 5, and 10 years, respectively (log-rank P ¼ .866;
Figure 1).
A single 30-day operative death (2.1%) occurred in
a 15-year-old boy with mitral valve IE. He had been under-
going active chemotherapy for acute lymphocytic leukemia
when he acutely experienced a catastrophic neurologic in-
sult due to septic cerebral embolization. He arrived at our
institution in a moribund state but was taken to the operating
room on admission day 2 in an effort to remove any addi-
tional source of embolization. However, he was declared
brain dead on admission day 11, despite all resuscitative
measures.
Of the remaining 5 deaths, 2 were associated with IE. An
infant with a structurally normal heart experienced worsen-
ing mitral valve insufficiency secondary to IE. Because of
the patient’s size at the development of infection, immediate
surgical therapy was deferred. The patient successfully
completed a 6-week antibiotic course but died 8 monthsTABLE 4. Univariate factors associated with surgery within 3 days of
diagnosis of infective endocarditis
Factor OR 95% CI
Presence of ventricular dysfunction 5.1 1.1-22.3
Staphylococcus aureus infection 4.7 1.3-16.9
Left-sided lesion 2.0 0.7-5.4
Septic embolization 1.9 0.6-5.4
Valvular involvement 1.6 0.4-6.8
Severe valvular insufficiency 1.2 0.4-3.8
OR, Odds ratio; CI, confidence interval.
ery c September 2013
FIGURE 1. Kaplan-Meier survival function stratified by treatment group.
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vular surgical evaluation was being performed. The second
IE-related mortality occurred in a surgical patient 7.1 years
after aortic valve replacement owing to an initial episode of
IE. He presented with IE of the prosthetic aortic valve but
succumbed to overwhelming sepsis soon after presentation.
No evidence of postoperative septic embolization was
found. The recurrence rate of IE was not significantly differ-
ent statistically, occurring in 2 nonsurgical patients (6.7%)
and 1 surgical patient (2.2%; P ¼ .330). The recurrence of
IE was significantly associated with increased mortality
(hazard ratio, 6.4; 95% confidence interval, 1.1-36.3).
Of the 38 surgical patients with native valve involvement,
19 (50.0%) required valve replacement and 19 underwent
successful native valve repair. Of the 19 patients requiring
valve replacement, 12 involved the aortic position, 5 the mi-
tral position, and 2 the right ventricular outflow tract. In the
aortic position, an aortic homograft was used in 8 patients,
a pulmonary autograft (Ross procedure) in 3, and a biopros-
thetic valve in 1. In the mitral position, a mechanical valve
was used in 4 patients and a composite valve in 1. In the
right ventricular outflow tract, a valved conduit was used
in both patients. Valve replacement was not significantly as-
sociated with mortality (P ¼ .435). Although no repeat
valve replacements occurred in the surgical group, 3 non-
surgical patients (10.0%) required valve replacement
(P ¼ .029) within the follow-up period after completing
their medical therapy course.
No significant differences were seen in mortality
(P¼ .562) or overall valve replacement (P¼ .469) betweenThe Journal of Thoracic and Capatients who had surgery more than 7 days versus within 3
days from diagnosis.
DISCUSSION
The continuously changing epidemiology and character-
istics of pediatric IE demands an evolving understanding of
treatment options and effect on outcomes to improve asso-
ciated morbidity and mortality. In the present study, 1 of the
largest reported pediatric surgical cohorts for IE, we found
that early surgery can be successfully performed in children
with high rates of native valve repair and low rates of recur-
rence and mortality.
Although no pediatric-specific surgical guidelines for
acute IE exist, established American Heart Association
adult guidelines have been endorsed by the American Acad-
emy of Pediatrics.12 We found that the indications for sur-
gery at our institution generally mirror those identified in
adult guidelines, including ventricular dysfunction, acute
valvular insufficiency, and uncontrolled infection. These
findings are similar to a recent, multicenter review describ-
ing the surgical indications of children with congenital heart
diseasewho developed IE.19 In addition, we found a number
of other factors associated with surgical intervention, in-
cluding the presence of left-sided vegetations, S aureus in-
fection, and a history of at least 1 previous embolization
event. These factors might represent an institutional bias to-
ward an aggressive surgical approach to minimize emboli-
zation risk owing to a high incidence of S aureus
infection in our cohort. However, additional appropriately
designed comparative studies would need to be conducted
to adequately evaluate the suitability of these indications.
Recent studies of adult populations have demonstrated im-
proved survival when surgery for IE was performed early in
specific patient subgroups.13-15 This benefit has been
attributed to several factors, including the early management
of a reversible cause of ventricular dysfunction, minimizing
embolization risk, and aggressive treatment of S aureus.
This is an important consideration owing to the highly
virulent nature of S aureus, because these children are more
likely to present with significantly advanced disease,
including aortic root involvement, valvular damage, and
abscess formation. In addition, changing trends in the
epidemiology have shown that S aureus has become 1 of the
most common pathogens responsible for IE,20,21 which was
reflected in our findings. Owing to the risk of advanced
disease, our institutional practice is to take children with
S aureus–related IE to the operating room as soon as
possible with the goal of minimizing the risk of
disseminated disease and septic embolization and improving
the possibility of native valve repair.
To date, information is limited concerning the effects of
surgical timing on the outcomes in children. Although
Nomura and colleagues7 demonstrated that surgical inter-
vention during the active phase of infection might berdiovascular Surgery c Volume 146, Number 3 509
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groups, the timing of the surgical intervention was not de-
scribed. Recently, Hickey and colleagues5 demonstrated
that surgery occurring within 1 week of diagnosis of a cere-
brovascular accident due to septic embolization was safe.
However, that study was limited by the small patient popu-
lation in the cerebrovascular accident group and lacked a de-
scription of the interval to surgery from the diagnosis of IE.
In the present study, we found that most surgical patients
underwent surgery within 7 days of diagnosis of IE and that
one half of those patients underwent surgery within 3 days.
Surgery within 3 days was significantly associated with
ventricular dysfunction or S aureus infection on univariate
analysis and S aureus infection on multivariate analysis.
As a result of our aggressive surgical approach, 50% of pa-
tients underwent native valve repair, no postoperative em-
bolization events occurred, and mortality was low.
Previous reports have described greater morbidity and
mortality in patients with ventricular dysfunction or S au-
reus infection.21 Thus, early surgical involvement in these
children might have an advantageous role in their treatment
by minimizing the risk of embolization and abscess forma-
tion in the case of staphylococcal infection and potentially
reverse the cause of ventricular dysfunction. We have dem-
onstrated early surgery can be safely performed in children,
with low postoperative mortality and acceptable medium-
to long-term outcomes.
Study Limitations
Although the present study is 1 of the largest pediatric
surgical cohorts with regard to IE, it was limited by its
single-center retrospective design of a moderate number
of patients. Although all available data were used in the sta-
tistical analyses, the negative endpoints described in the
present study might have resulted from a lack of statistical
power. Therefore, it would be difficult to exclude the possi-
bility of a type II error, and additional studies with greater
numbers of patients are required to establish negative
associations.
The design of the present study prevented a direct com-
parison between the surgical and nonsurgical groups owing
to an inherent selection bias. Attempts to alleviate this bias
using statistical methods, such as propensity scoring, were
not possible owing to the small study size. Thus, the find-
ings of the present study should be interpreted in the context
of the descriptive nature of the data. Although the present
study was not designed to directly compare the outcomes
of early surgery with those of late surgery or medical ther-
apy alone, it has demonstrated that early surgery can be per-
formed safely and effectively in children. Finally,
significant associations with respect to surgical indications
and timing represent the practice of our large, US tertiary-
care children’s hospital and might not be generalized to
dissimilar institutions or locations.510 The Journal of Thoracic and Cardiovascular SurgCONCLUSIONS
Early surgical intervention in children with acute IE can
be performed safely with excellent results. The benefit of
early surgery might play a significant role in the treatment
of IE caused by S aureus by minimizing the risk of progres-
sive cardiac disease and septic embolization. Furthermore,
early surgery, in conjunction with appropriate antibiotic
therapy, can be performed in children safely, with excellent
results, even in the acute phase of infection. Additional
study is required to better understand the overall indications
for surgery and those who might benefit most from early
surgical intervention.References
1. Day MD, Gauvreau K, Shulman S, Newburger JW. Characteristics of children
hospitalized with infective endocarditis. Circulation. 2009;119:865-70.
2. Coward K, Tucker N, Darville T. Infective endocarditis in Arkansan children
from 1990 through 2002. Pediatr Infect Dis J. 2003;22:1048-52.
3. Rosenthal LB, Feja KN, Levasseur SM, Alba LR, Gersony W, Saiman L. The
changing epidemiology of pediatric endocarditis at a children’s hospital over
seven decades. Pediatr Cardiol. 2010;31:813-20.
4. DelmoWalter EM,MusciM, Nagdyman N, HublerM, Berger F, Hetzer R.Mitral
valve repair for infective endocarditis in children. Ann Thorac Surg. 2007;84:
2059-65.
5. Hickey EJ, Jung G, Manlhiot C, Sakopoulos AG, Caldarone CA, Coles JG,
et al. Infective endocarditis in children: native valve preservation is frequently
possible despite advanced clinical disease. Eur J Cardiothorac Surg. 2009;35:
130-5.
6. Karaci AR, Aydemir NA, Harmandar B, Sasmazel A, Saritas T, Tuncel Z, et al.
Surgical treatment of infective valve endocarditis in children with congenital
heart disease. J Card Surg. 2012;27:93-8.
7. Nomura F, Penny DJ, Menahem S, Pawade A, Karl TR. Surgical intervention
for infective endocarditis in infancy and childhood. Ann Thorac Surg. 1995;60:
90-5.
8. Vikram HR, Buenconsejo J, Hasbun R, Quagliarello VJ. Impact of valve surgery
on 6-month mortality in adults with complicated, left-sided native valve endocar-
ditis: a propensity analysis. JAMA. 2003;290:3207-14.
9. Niwa K, NakazawaM, Tateno S, YoshinagaM, Terai M. Infective endocarditis in
congenital heart disease: Japanese national collaboration study. Heart. 2005;91:
795-800.
10. Weber R, Berger C, Balmer C, Kretschmar O, Bauersfeld U, Pretre R, et al.
Interventions using foreign material to treat congenital heart disease in children
increase the risk for infective endocarditis. Pediatr Infect Dis J. 2008;27:
544-50.
11. Yoshinaga M, Niwa K, Niwa A, Ishiwada N, Takahashi H, Echigo S, et al. Risk
factors for in-hospital mortality during infective endocarditis in patients with
congenital heart disease. Am J Cardiol. 2008;101:114-8.
12. Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr, Bolger AF, Levison ME,
et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management
of complications: a statement for healthcare professionals from the Committee
on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovas-
cular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and
Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed
by the Infectious Diseases Society of America. Circulation. 2005;111:e394-434.
13. Bishara J, Leibovici L, Gartman-Israel D, Sagie A, Kazakov A, Miroshnik E,
et al. Long-term outcome of infective endocarditis: the impact of early surgical
intervention. Clin Infect Dis. 2001;33:1636-43.
14. Kim DH, Kang DH, Lee MZ, Yun SC, Kim YJ, Song JM, et al. Impact of early
surgery on embolic events in patients with infective endocarditis. Circulation.
2010;122(11 Suppl):S17-22.
15. Lalani T, Cabell CH, Benjamin DK, Lasca O, Naber C, Fowler VG Jr, et al. Anal-
ysis of the impact of early surgery on in-hospital mortality of native valve endo-
carditis: use of propensity score and instrumental variable methods to adjust for
treatment-selection bias. Circulation. 2010;121:1005-13.
16. Kang DH, KimYJ, Kim SH, Sun BJ, KimDH, Yun SC, et al. Early surgery versus
conventional treatment for infective endocarditis. N Engl J Med. 2012;366:
2466-73.ery c September 2013
Shamszad et al Congenital Heart Disease17. Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T, et al. Proposed
modifications to the Duke criteria for the diagnosis of infective endocarditis.
Clin Infect Dis. 2000;30:633-8.
18. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al.
Recommendations for chamber quantification: a report from the American Soci-
ety of Echocardiography’s Guidelines and Standards Committee and the Cham-
ber Quantification Writing Group, developed in conjunction with the European
Association of Echocardiography, a branch of the European Society of Cardiol-
ogy. J Am Soc Echocardiogr. 2005;18:1440-63.The Journal of Thoracic and Ca
D19. Murakami T, Niwa K, Yoshinaga M, Nakazawa M. Factors associated with sur-
gery for active endocarditis in congenital heart disease. Int J Cardiol. 2012;157:
59-62.
20. Alshammary A, Hervas-Malo M, Robinson JL. Pediatric infective endocarditis:
has Staphylococcus aureus overtaken viridans group streptococci as the predom-
inant etiological agent? Can J Infect Dis Med Microbiol. 2008;19:63-8.
21. Selton-Suty C, Celard M, Le Moing V, Doco-Lecompte T, Chirouze C, Iung B,
et al. Preeminence of Staphylococcus aureus in infective endocarditis: a 1-year
population-based survey. Clin Infect Dis. 2012;54:1230-9.rdiovascular Surgery c Volume 146, Number 3 511
C
H
